Replies to post #41539 on Biotech Values

[ThomasS]

RPRX: forget SGEN next week; get RPRX moving North again...
The financing "overhang" should evaporate. I am still amazed at the low market cap.
(SGEN is just about fully valued here, imo. For now.)